Tango Therapeutics to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference

Rhea-AI Summary

Tango Therapeutics, a biotechnology firm focused on precision cancer medicines, will participate in a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 15, 2022, at 11:20 AM PT in Rancho Palos Verdes, CA. Investors can access a live webcast on the company's website under the 'Events & Presentations' section, with a replay available for 30 days afterward. Tango applies the principle of synthetic lethality to explore cancer therapies, targeting critical areas, including tumor suppressor gene loss.

CAMBRIDGE, Mass., June 08, 2022 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that members of the management team are scheduled to participate in a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference on Wednesday, June 15 at 11:20 AM PT in Rancho Palos Verdes, CA.

A live webcast of the event will be available under the "Events & Presentations" tab on the “Investors” page on the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 30 days following the presentation.

About Tango Therapeutics

Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. For more information, please visit www.tangotx.com.

Investor Contact:
Sam Martin/Michael Barron
Argot Partners
tango@argotpartners.com

Media Contact:
Joshua R. Mansbach
Argot Partners
tango@argotpartners.com

FAQ

What event will Tango Therapeutics participate in on June 15, 2022?

Tango Therapeutics will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference.

What time is Tango Therapeutics' fireside chat at the Goldman Sachs conference?

The fireside chat is scheduled for 11:20 AM PT.

How can I watch the fireside chat for Tango Therapeutics?

The fireside chat will be available via a live webcast on the company's website under the 'Events & Presentations' tab.

Will there be a replay of the Tango Therapeutics fireside chat?

Yes, a replay of the webcast will be available for 30 days following the event.

What is the focus of Tango Therapeutics in cancer treatment?

Tango Therapeutics focuses on discovering novel drug targets using the genetic principle of synthetic lethality for precision cancer medicine.